Skip to main content
Equibles
LH logo

LH · Labcorp Holdings Inc.

Track LH — free

Use LH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$326.89 -4.61 (-1.39%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$26.75B
Shares
81.10M

LH metrics

96 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$326.89
Market cap
$26.75B

Price action

19 metrics
Price change (1W)
-1.5%
Price change (30D)
+4.7%
Price change (3M)
+27.0%
Price change (6M)
+20.1%
Price change (YTD)
+32.1%
Price change (1Y)
+21.1%
Trailing year
Price change (5Y)
—
52-week high
$339.34
52-week low
$246.64
Change from 52-week high
-2.3%
Change from 52-week low
+34.4%
Annualized volatility
23.3%
Beta
0.3
RSI (14D)
61.6
Price vs SMA 50
+8.6%
Price vs SMA 200
+20.4%
Avg volume (3M)
672,286
Relative volume
0.8
Average dollar volume
$199.06M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
81.10M

Valuation

12 metrics
P / E (TTM)
27.4
Trailing earnings · reciprocal yield 3.6%
PEG ratio
1.0
EV / revenue
2.3×
reciprocal yield 44.2%
EV / EBITDA
14.8×
reciprocal yield 6.8%
EV / EBIT
21.7×
reciprocal yield 4.6%
P / sales
1.9×
reciprocal yield 53.6%
P / book
3.1
reciprocal yield 32.2%
FCF yield
4.3%
TTM · current market cap
Buyback yield
2.6%
P / FCF
23.2
reciprocal yield 4.3%
P / operating cash flow
16.3
reciprocal yield 6.1%
Earnings yield
3.7%

Historical valuation

8 metrics
P / E historical average (3Y)
26.6×
reciprocal yield 3.8%
P / E historical average (5Y)
19.4×
reciprocal yield 5.1%
EV / revenue historical average (3Y)
2.0×
reciprocal yield 49.5%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.5%
EV / EBIT historical average (3Y)
23.2×
reciprocal yield 4.3%
EV / EBIT historical average (5Y)
23.2×
reciprocal yield 4.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.9%
Trailing 12 months
Payout ratio
23.9%
Shareholder yield
3.5%
Dividend / share (TTM)
$2.88
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-28

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
28.9%
Operating margin
10.4%
Trailing 12 months
Net margin
7.0%
Gross profit (TTM)
$4.14B
Operating profit (TTM)
$1.50B
Net income (TTM)
$1.00B
Trailing 12 months
Diluted EPS (TTM)
$12.09
FCF margin
8.1%
Effective tax rate
18.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$98.35

Growth

11 metrics
Revenue growth YoY
+5.8%
Year over year
Net income growth YoY
+25.6%
Revenue (TTM)
$14.35B
Trailing 12 months
EPS growth YoY
+28.2%
Shares change YoY
-2.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.6%
Revenue CAGR (5Y)
0.0%
EPS CAGR (3Y)
-9.2%
EPS CAGR (5Y)
-5.2%
FCF CAGR (3Y)
-7.6%
FCF CAGR (5Y)
-7.2%

Quality

14 metrics
Return on equity
11.6%
Return on assets
5.4%
Debt / equity
0.7
Current ratio
1.8
EBITDA (TTM)
$2.19B
Free cash flow (TTM)
$1.16B
Quick ratio
1.5
Interest coverage
6.6
Net debt / EBITDA
2.6
Return on invested capital
8.5%
Trailing 12 months
Net cash
−$5.72B
Latest balance sheet
Cash & equivalents
$141.80M
Total assets
$18.53B
Total debt
$5.86B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.64B
Capital expenditures (TTM)
$483.20M
R&D (TTM)
—
SG&A (TTM)
$2.22B
Stock compensation (TTM)
$125.50M
R&D / revenue
—
Stock compensation / revenue
0.9%

Ownership (13F)

3 metrics
13F filers
1,048
13F filer change QoQ
+24
Institutional ownership
98.2%

Short interest

3 metrics
Short interest
2.4%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.47M
Insider-sentiment score
40 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 920148 CUSIP 504922105 13F (30d) 598 filings 578 filers Visit website Investor relations